Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis

Author:

Furie Richard1,Rovin Brad H.1,Houssiau Frédéric1,Malvar Ana1,Teng Y.K. Onno1,Contreras Gabriel1,Amoura Zahir1,Yu Xueqing1,Mok Chi-Chiu1,Santiago Mittermayer B.1,Saxena Amit1,Green Yulia1,Ji Beulah1,Kleoudis Christi1,Burriss Susan W.1,Barnett Carly1,Roth David A.1

Affiliation:

1. From the Division of Rheumatology, Northwell Health, Donald and Barbara Zucker School of Medicine at Hofstra–Northwell, Great Neck, NY (R.F.); the Division of Nephrology, Ohio State University, Columbus (B.H.R.); Pôle de Pathologies Rhumatismales Inflammatoires et Systémiques, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, and Service de Rhumatologie, Cliniques Universitaires Saint-Luc — both in Brussels (F.H.); Organización Médica de Investigación, Buenos Aires (A.M....

Funder

GSK

Publisher

Massachusetts Medical Society

Subject

General Medicine

Cited by 602 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Systemic lupus erythematosus in childhood and adolescence;Dubois' Lupus Erythematosus and Related Syndromes;2025

2. B cells and generation of antibodies;Dubois' Lupus Erythematosus and Related Syndromes;2025

3. Future directions;Dubois' Lupus Erythematosus and Related Syndromes;2025

4. Management of lupus nephritis;Dubois' Lupus Erythematosus and Related Syndromes;2025

5. Targeted therapies in SLE;Dubois' Lupus Erythematosus and Related Syndromes;2025

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3